In yesterday’s Wall Street session, Metlife Inc (NYSE:MET) shares traded at $60.01, up 0.05% from the previous session.
18 analysts cover Metlife Inc (NYSE:MET), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $85.00 and a low of $69.40, we find $80.00. Given the previous closing price of $59.98, this indicates a potential upside of 33.38 percent. MET stock price is now -3.96% away from the 50-day moving average and -1.86% away from the 200-day moving average. The market capitalization of the company currently stands at $45.13B.
The stock has received a hold rating from 6 analysts and a buy rating from 11. Brokers who have rated the stock have averaged $77.88 as their price target over the next twelve months.
With the price target of $71, Deutsche Bank recently initiated with Hold rating for Metlife Inc (NYSE: MET).
In other news, DEBEL MARLENE, EVP & Chief Risk Officer sold 9,391 shares of the company’s stock on Aug 09. The stock was sold for $593,323 at an average price of $63.18. Upon completion of the transaction, the EVP & Chief Risk Officer now directly owns 77,638 shares in the company, valued at $4.66 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 02, EVP, Global Tech. & Ops. PAPPAS BILL sold 2,857 shares of the business’s stock. A total of $202,733 was realized by selling the stock at an average price of $70.96. This leaves the insider owning 48,915 shares of the company worth $2.94 million. Insiders disposed of 480,454 shares of company stock worth roughly $28.83 million over the past 1 year. A total of 16.19% of the company’s stock is owned by insiders.
On Thursday morning Metlife Inc (NYSE: MET) stock kicked off with the opening price of $59.99. During the past 12 months, Metlife Inc has had a low of $48.95 and a high of $77.36. According to the stock market information, the enterprise value for the company is $66.35B, which is based on a 22.06 price-to-earnings ratio, a 2.35 price-to-earnings-growth ratio, and a beta of 1.06. The fifty day moving average price for MET is $62.45 and a two-hundred day moving average price translates $61.09 for the stock.
The latest earnings results from Metlife Inc (NYSE: MET) was released for Sep, 2023. According to the Insurance – Life Company, earnings per share came in at $1.94, beating analysts’ expectations of $1.87 by 0.07. This compares to $1.08 EPS in the same period last year. The net profit margin was 3.30% and return on equity was 6.59% for MET. The company reported revenue of $16.62 billion for the quarter, compared to $15.47 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 7.43 percent. For the current quarter, analysts expect MET to generate $17.68B in revenue.
Metlife Inc(MET) Company Profile
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.
